Clinical Diagnostics Market Size

Report on Industry Size & Market Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Point of Care Diagnostics Market Trends and is Segmented by Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), Product (Instruments, Reagents, and Other Products), End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers values (in USD million) for the above segments.

Clinical Diagnostics Market Size

Clinical Diagnostics Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 84.18 Billion
Market Size (2029) USD 109.92 Billion
CAGR (2024 - 2029) 5.48 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Clinical Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Clinical Diagnostics Market Analysis

The Clinical Diagnostics Market size is estimated at USD 84.18 billion in 2024, and is expected to reach USD 109.92 billion by 2029, growing at a CAGR of 5.48% during the forecast period (2024-2029).

Owing to the COVID-19 pandemic, there had been an increase in lab testing, which saw demand grow even more rapidly to keep pace with the suspected cases of COVID-19. According to the Atlantic Monthly Group, there was a tremendous increase globally in COVID-19 tests, rising from 760,441 tests in September 2020 to 964,792 tests by October 2020. Thus, the rising number of tests owing to the constant upsurge in patients and funding by governments were the factors responsible to escalate the demand for COVID-19 test kits and drove the overall market growth exponentially. In addition, the demand for clinical diagnostics is expected to remain constant during the post-pandemic period due to the emergence of a mutant strain of the COVID-19 virus, thereby contributing to the growth of the market over the five years.

The market is expected to grow due to the increasing incidence of infectious as well as chronic diseases and the increasing adoption of automated platforms. According to the World Health Organization report in February 2022, each year, approximately 400,000 children and adolescents of 0-19 years old develop cancer. The same source also mentioned that the most common types of childhood cancers include leukemias, brain cancers, lymphomas, and solid tumors, such as neuroblastomas and Wilms tumors. The report Published by International Agency for Research on Cancer (IARC) in December 2020 that the global cancer burden has risen to 19.3 million cases. and thus, due to the high prevalence of cancer around the world, the demand for effective clinical diagnostics, thereby contributing to the growth of the market. Also, the rising infectious diseases are expected to contribute to the growth of the clinical diagnostics market. For instance, the report published by the World Health Organization in November 2021, reported that more than 1.0 million sexually transmitted infections are acquired globally and most of them are asymptomatic. It also reported that every year there are an estimated 374.0 million new infections with 1 out of 4 sexually transmitted infections: gonorrhea, chlamydia, trichomoniasis, and syphilis.

Owing to the increase in chronic diseases, the demand for healthcare systems is also increasing. Clinical diagnostics have, thus, proven to be beneficial in chronic disease conditions and are found to be valuable for disease prevention, detection, and management. Thus, the increasing incidence of chronic diseases is expected to propel the overall market further.

Clinical Diagnostics Market Trends

This section covers the major market trends shaping the Clinical Diagnostics Market according to our research experts:

Lipid Panel Tests Segment is Expected to Register Good Growth in the Forecast Period

The lipid panel is a blood test that measures the lipids, fats, and fatty substances used as a source of energy by the body. The lipid panel includes tests for total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, cholesterol/HDL ratio, and non-HDL cholesterol.

A lipid panel measures the level of specific lipids in the blood to assess the risk of cardiovascular disease and is used in screening populations to identify subjects with a high risk of developing a cardiac event. The British Heart Foundation reported in January 2022 that the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million), and atrial fibrillation (60 million). Such a large prevalence globally is fueling the growth of the market. Furthermore, the Centers for Disease Control and Prevention (CDC) article updated in September 2021 reported that approximately 6.5 million people aged 40 and older in the United States have peripheral arterial disease. Additionally, the MDPI Journal research article published in September 2021 reported that the worldwide prevalence of peripheral arterial disease (PAD) is estimated to be 3%-12%, affecting nearly 27 million people in America and Europe. The same source also reported that in Europe, the prevalence of PAD is estimated at around 17.8% between the ages of 45 and 55. Thus, these studies showing the high burden of peripheral vascular diseases are expected to boost the growth of the market. Hence, with an increase in the prevalence and incidence rate of cardiovascular diseases, there is an increase in the requirement for lipid profile testing at an early stage, which is driving the lipid panel segment.

Also, the increasing number of product launches for lipid panel tests is also expected to contribute to the growth of the studied segment over the forecast period. For instance, in October 2022, Boston Heart Diagnostics announced the availability of LipoMap. This panel of 33 lipid, lipoprotein, and apolipoprotein tests is performed via high-resolution 600 MHz nuclear magnetic resonance and is one of the most comprehensive assessments of lipid metabolism commercially available.

Key companies are focusing on novel product developments and launches to leverage potential opportunities. Hence, the segment is estimated to grow over the forecast period due to the aforementioned factors.

Clinical Diagnostics Market: Estimated Incidence of Cancer Cases (in Million), By Region, Global,2020-2040

North America is Expected to Dominate the Clinical Diagnostics Market Over the Forecast Period

The market for clinical diagnostics in North America is majorly driven by the increasing geriatric population, rising patient awareness about the value of laboratory tests, and the rising prevalence of infectious and chronic disease patients.  

For instance, the data published by the American Cancer Society in 2022 mentioned that a total 1.9 million new cancer cases are expected to occur in the United States in 2022. Also, the Centers for Disease Control and Prevention in March 2021 published that more than 1 in 7, which is 15% of the United States adults are estimated to have chronic Kidney disease in 2021. such prevalence of chronic diseases is expected to drive the growth of the market.

Also, the rising funding activities to support the growth of clinical diagnostics are expected to contribute to the growth of the market in this region. For instance, in September 2020, the National Institutes of Health, US, announced its plan to give funding of USD 129.3 million to nine companies, including MatMaCorp, Maxim Biomedical Inc., MicroGEM International, etc., to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

This has led to a higher demand for better treatment with efficient management, further driving the market in the North America. Hence, the increasing prevalence of infectious and chronic diseases and the growing awareness of the value of laboratory tests are expected to fuel the market growth in the country.

Clinical Diagnostics Market- Growth Rate By Region

Clinical Diagnostics Industry Overview

The market is highly competitive and consists of global and local players. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known. The major key players in the market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, and Roche Diagnostics.

Clinical Diagnostics Market Leaders

  1. Bio-Rad Laboratories

  2. Danaher Corporation

  3. F. Hoffmann-La Roche AG

  4. Abbott Laboratories

  5. bioMérieux

*Disclaimer: Major Players sorted in no particular order

Clinical Diagnostics Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Clinical Diagnostics Market News

  • May 2022: Qiagen Inc. launched NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission. The emergence of this assay is allowing the company to expand its product portfolio in laboratory testing which ultimately helps the market growth owing to the innovative tests.
  • March 2022: Mindray launched the BC-700 Series, a hematology analyzer series that assists in both blood count and erythrocyte sedimentation rate tests.

Clinical Diagnostics Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Infectious and Chronic Diseases

      2. 4.2.2 Increasing Adoption of Automated Platforms

    3. 4.3 Market Restraints

      1. 4.3.1 Affordability for High-end Molecular Diagnostics

      2. 4.3.2 Limitations Associated with Reimbursement Scenario

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size in Value)

    1. 5.1 By Test

      1. 5.1.1 Lipid Panel

      2. 5.1.2 Liver Panel

      3. 5.1.3 Renal Panel

      4. 5.1.4 Complete Blood Count

      5. 5.1.5 Electrolyte Testing

      6. 5.1.6 Infectious Disease Testing

      7. 5.1.7 Other Tests

    2. 5.2 By Product

      1. 5.2.1 Instruments

      2. 5.2.2 Reagents

      3. 5.2.3 Other Products

    3. 5.3 By End User

      1. 5.3.1 Hospital Laboratory

      2. 5.3.2 Diagnostic Laboratory

      3. 5.3.3 Point-of-care Testing

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMerieux

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 Siemens AG

      7. 6.1.7 Hologic Inc.

      8. 6.1.8 Qiagen NV

      9. 6.1.9 F. Hoffmann-La Roche AG

      10. 6.1.10 Thermo Fisher Scientific

      11. 6.1.11 Quest Diagnostics Inc.

      12. 6.1.12 Sysmex Corporation

      13. 6.1.13 Sonic Healthcare Ltd

      14. 6.1.14 Charles River Laboratories

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Clinical Diagnostics Industry Segmentation

As per the scope of the report, a clinical diagnostic test is a type of medical test performed to aid in the diagnosis or detection of any disease. These tests play a vital role in the prevention, control, and surveillance of any disease. Clinical diagnostics help improve patient care, contribute to consumer safety, and reduce healthcare spending. The Clinical Diagnostics Market is Segmented by Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and other Tests), Product (Instruments, Reagents, and Other Products), End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, and Other End Users), and Geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated sizes and trends for 17 countries across major regions globally. The report offers values (in USD million) for the above segments.

By Test
Lipid Panel
Liver Panel
Renal Panel
Complete Blood Count
Electrolyte Testing
Infectious Disease Testing
Other Tests
By Product
Other Products
By End User
Hospital Laboratory
Diagnostic Laboratory
Point-of-care Testing
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Clinical Diagnostics Market Research FAQs

The Clinical Diagnostics Market size is expected to reach USD 84.18 billion in 2024 and grow at a CAGR of 5.48% to reach USD 109.92 billion by 2029.

In 2024, the Clinical Diagnostics Market size is expected to reach USD 84.18 billion.

Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Abbott Laboratories and bioMérieux are the major companies operating in the Clinical Diagnostics Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Clinical Diagnostics Market.

In 2023, the Clinical Diagnostics Market size was estimated at USD 79.81 billion. The report covers the Clinical Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Clinical Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

The emerging trends in Clinical Diagnostics Technology are a) Personalized medicine b) Point-of-care testing

Clinical Diagnostics Industry Report

The global clinical diagnostics market is flourishing, driven by the increasing need to diagnose and manage chronic and infectious diseases. With a focus on tests like lipid panels, liver panels, and complete blood counts, the market is witnessing significant growth in the diagnostics of cardiovascular diseases due to rising awareness and preventive healthcare. Product-wise, the diagnostics market includes advanced instruments, reagents, and other products. Instruments are set to dominate due to technological innovations enhancing diagnostic accuracy and efficiency. Key end-users such as hospital laboratories, diagnostic centers, and point-of-care settings are crucial in disease management, with hospitals holding a major market share. Geographically, North America leads with its advanced healthcare infrastructure, while the Asia-Pacific region shows promising growth fueled by healthcare investments. As the diagnostics industry evolves, the demand for diverse and sophisticated diagnostics solutions from clinical diagnostics companies is surging, indicating a robust expansion in diagnostics market size. For detailed market insights and the forecast outlook provided by Mordor Intelligence™, including the biggest marijuana companies, download a free sample PDF of the industry analysis.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Clinical Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)